Search the Newsreel

Odyssey Marine Exploration (OMEX) details deep Q2 loss and $900M AOM merger plan

Odyssey Therapeutics (ODTX) Stock Looks Reasonable As AI Research News Lands

Odyssey Therapeutics (ODTX) stock has seen a 28.9% increase year-to-date, fueled by an AI-enabled research partnership with Evotec. Despite this, the company's valuation checks suggest it is not a clear bargain, trading at a price-to-book ratio of about 2.4x, which is in line with …

Thyssenkrupp nucera AG & Co. KGaA: SOEC-Neuausrichtung führt zu Anpassung der EBIT-Prognose 2025/26; Aktualisierung der Auftragseingangs- und Umsatz-Erwartung auf Basis bisheriger Geschäftsentwicklung

Thyssenkrupp Nucera (WKN NCA000, ISIN DE000NCA0001) - Nachricht anzeigen - News

EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: SOEC-Neuausrichtung führt zu Anpassung der EBIT-Prognose 2025/26; Aktualisierung der Auftragseingangs- und Umsatz-Erwartung auf Basis bisheriger Geschäftsentwicklung - boerse.de

York Space Systems (NYSE:YSS) Reaches New 1-Year Low After Insider Selling

Odyssey Therapeutics (ODTX) Looks Fully Valued As Earnings And Evotec Deal Refocus Attention

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Why Odyssey Therapeutics Stock Is Back In Focus Odyssey Therapeutics (ODTX) is drawing attention after reporting second quarter 2026 results that showed a larger …

York Space Systems (NYSE:YSS) Major Shareholder Sells 201,504 Shares of Stock

BlackRock Portfolio Management sold 201,504 shares of York Space Systems (NYSE:YSS) stock on August 6th at an average price of $11.60, totaling approximately $2.34 million. This sale reduced their ownership by 1.19% to 16.7 million shares. York Space Systems stock experienced a drop of …

Top Odyssey Therapeutics (ODTX) Competitors 2026

This article analyzes Odyssey Therapeutics (ODTX) against five of its biotechnology competitors: Relay Therapeutics (RLAY), Alumis (ALMS), Arcus Biosciences (RCUS), Legend Biotech (LEGN), and Telix Pharmaceuticals (TLX). MarketBeat compares these companies based on various financial metrics, analyst ratings, profitability, and media sentiment to help …

Odyssey Therapeutics Hits $900M Valuation In Nasdaq Debut, Stock Climbs 13% Before Diving Lower

Will York Space Systems (YSS) CFO Transition Subtly Reshape Its Financial Discipline And Growth Ambitions?

Odyssey Marine Exploration Inc (OMEX) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Odyssey Marine Exploration Inc (OMEX), noting that no earnings forecast score is currently available for the company, while the industry average is 7.63. It also includes the latest stock price, market capitalization, and a comparison with peer …

Odyssey Therapeutics (NASDAQ:ODTX) Given New $29.00 Price Target at JPMorgan Chase & Co.

JPMorgan Chase & Co. has increased its price target for Odyssey Therapeutics (NASDAQ:ODTX) to $29.00 from $26.00, maintaining an "overweight" rating and suggesting a potential upside of 32.12%. This positive outlook is supported by a "Moderate Buy" consensus rating from analysts and recent insider …

York Space Systems (NYSE:YSS) Shares Down 11.5% Following Analyst Downgrade

York Space Systems (NYSE:YSS) experienced an 11.5% stock price drop following an analyst downgrade from "hold" to "sell" by Wall Street Zen. Despite this, the consensus analyst rating remains "Moderate Buy" with an average price target of $34.90. The company also reported a significant …

Odyssey Therapeutics, Inc. Q2 2026: Revenue $0 EPS $(1.74) — 10-Q Summary

Odyssey Therapeutics, Inc. reported Q2 2026 results, showing $0 revenue and a net loss of $52.8M, or $(1.74) EPS. The company noted a shift from collaboration revenue and stated that proceeds from its IPO and a private placement extend its cash runway into the …

BlackRock unit trims York Space Systems (YSS) stake with 661,999-share sale

BlackRock Portfolio Management LLC, a 10% owner of York Space Systems Inc. (YSS), reported indirect sales of 661,999 common shares on August 4-5, 2026. The sales occurred at prices ranging from $13.49 to $16.00 per share, totaling approximately $10.02 million. These shares are held …

Odyssey Therapeutics (Nasdaq: ODTX) reports $91.1M loss, $433.1M cash

Odyssey Therapeutics (ODTX) reported a net loss of $91.1 million for the first half of 2026, an increase from $79.7 million in the same period last year, primarily due to continued investment in its pipeline and higher non-cash contingent consideration expense. Following a May …

Biotech Stocks At 52-Week Highs - BVS, TVTX, ODTX, CRL Climb With Q2 Results, ACRS

(RTTNews) - The following biotech stocks reached a 52-week high on August 5, 2026, primarily driven by positive quarterly reports. Bioventus Inc. (BVS) Bioventus is a medical device company that focuses on technology for pain management and musculoskeletal issues. The company touched a 52-week …

Odyssey Marine (Nasdaq: OMEX) details exploration-stage seabed mining stakes

Odyssey Marine Exploration, Inc. (OMEX) filed Amendment No. 2 to its 2025 annual report, clarifying its mineral property disclosures in response to an SEC comment. The amendment specifies that its mining operations are material, detailing indirect, minority interests in exploration-stage projects like CIC Limited …

Evotec and Odyssey Therapeutics Enter AI-Enabled R&D Collaboration in Autoimmune and Inflammatory Diseases

Collaboration combines Odyssey's disease biology expertise with Evotec's AI-enabled discovery platform, advanced screening capabilities and proprietary compound libraries to support advancement of Odyssey's discovery-stage programs Evotec to deliver validated hit series across multiple high-value targets for large inflammatory and autoimmune diseases with high unmet …

York Space Systems (NYSE: YSS) taps Brian Frantz as interim CFO

York Space Systems (NYSE: YSS) has appointed Brian D. Frantz, its Chief Accounting Officer, as interim Chief Financial Officer, effective August 14, 2026. This appointment follows the departure of current CFO Kevin Messerle, who will remain in his role until the filing of the …

York Space Systems Announces Chief Financial Officer Transition

York Space Systems announced that Kevin Messerle will step down as CFO, effective August 14, 2026. Brian Frantz, currently Chief Accounting Officer, will serve as interim CFO. Frantz brings over three decades of financial leadership experience and played a key role in the company's …

Odyssey Therapeutics Inc: Odyssey Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Odyssey Therapeutics reported its second-quarter 2026 financial results, highlighted by positive clinical proof-of-concept data for its OD-001 program and plans to advance it into Phase 2b monotherapy and Phase 2a combination trials later in 2026. The company also expects to file a Clinical Trial …

Odyssey Therapeutics (ODTX) Earnings Date and Reports 2026

Lowey Dannenberg, P.C. is Investigating York Space Systems, Inc. (NYSE: YSS) for Potential Violations of the Federal Securities Laws

Lowey Dannenberg P.C. is investigating York Space Systems, Inc. (NYSE: YSS) for potential federal securities law violations. This investigation follows a Wolfpack Research report alleging that the Pentagon's decision to eliminate a key program was due to "severe disappointment in York," claiming the company …

ThyssenKrupp Nucera Aktie: 638 Millionen Auftragsbestand

York Space Systems(YSS.US) 10% Shareholder Sells US$3.11 Million in Common Stock

A 10% shareholder of York Space Systems (YSS.US) recently sold 65,000 shares of common stock for a total of US$3.11 million. The transaction was executed at a price of US$47.9 per share. This sale indicates a significant divestment by a major stakeholder in the …

York Space Systems (NYSE:YSS) Major Shareholder Sells 63,390 Shares of Stock

BlackRock Portfolio Management, a major shareholder in York Space Systems (NYSE:YSS), sold 63,390 shares worth approximately $970,501 on July 29th, and an additional 140,823 shares for about $2.14 million on July 30th, reducing its position by 0.36%. These sales occurred as York Space Systems …

Rocket Lab Lands Launch Contract, Space Force Taps Vendors For $981 Million Program

Rocket Lab stock rises after landing new Electron launch deals. Space Force taps Rocket Lab, 14 vendors for $981 mil program. Continue Reading

Odyssey Marine Exploration Inc (OMEX) Valuation: PE, PB & Fair Value Analysis

The article provides a valuation analysis for Odyssey Marine Exploration Inc (OMEX), noting its current valuation score of 9.74 and ranking 6 out of 126 in the Metals & Mining industry. It highlights the company's P/E ratio of -0.55, which is significantly below its …

York Space Systems (NYSE:YSS) Stock Price Down 7.6% - Here's Why

York Space Systems (NYSE:YSS) saw its stock price drop by 7.6% after reporting a significant quarterly earnings miss, with a loss of $1.51 per share against an expected loss of $0.12. Analyst ratings are mixed, with Raymond James downgrading the stock to "market perform," …

OMEX|Odyssey Marine Exploration Inc|Price:0.659|Chg%:-0.014

Odyssey Marine Exploration Inc.'s stock (OMEX) is currently trading at $0.648, experiencing a decline of 3.72%. The company, which specializes in seafloor critical mineral projects, shows relatively stable fundamentals and good growth potential, but its stock has performed weakly over the past month. Despite …

York Space Systems Number of Employees 2026 | Employee Count & Headcount Data

York Space Systems LLC has approximately 564 total employees as of March 2026, representing a 27.4% growth since 2023. The company, headquartered in Denver, Colorado, is actively hiring with 101 active job postings in 2026, an 8.2% increase from 2025. Employee sentiment is currently …

Odyssey Marine Exploration Inc (OMEX) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides details about Odyssey Marine Exploration Inc (OMEX) dividends and stock splits. It notes that the company has not distributed any dividends in the past five years. The page displays current stock information and market capitalization for OMEX.

Odyssey Marine Exploration Inc (OMEX) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Odyssey Marine Exploration Inc (OMEX), focusing on its support and resistance levels, various technical indicators, and moving averages. As of July 27, 2026, OMEX has a price momentum score of 5.19 and is trading between a resistance …

109,000,000 Common Stock of York Space Systems, Inc. are subject to a Lock-Up Agreement Ending on 28-JUL-2026.

Approximately 108.44 million common shares of York Space Systems, Inc. are subject to a lock-up agreement that ends on July 28, 2026. This lock-up period began on January 28, 2026, and prevents officers, directors, and major holders, including AE Industrial Partners, from selling or …